The global circulating tumor cells market is positioned for substantial growth, with a projected value of USD 28.4 billion by 2030. This translates to a compelling CAGR (compound annual growth rate) of 13.4% during the forecast period of 2023-2030, according to a recent market analysis. The market was estimated at USD 10.4 billion in 2022. This press release explores the...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek